EMUC15: Best unmoderated posters in bladder and kidney cancers

15 November 2015 Joel Vega

The 7th EMUC has awarded today the three best unmoderated abstract posters to researchers from Italy, Israel and Belgium. Session chairpersons Profs. Bertrand Tombal and Harriet Thoeny cited the innovative approaches and insights on managing bladder and kidney cancers. Below is the list of winners:

First Prize
Necchi, A, et al., “Neoadjuvant sorafenib, gemcitabine and cisplatin (SCC) for muscle-invasive urothelial bladder cancer (UBC): Updated clinical and transitional findings of an open-label, single group, phase 2 study” (Italy)

Second Prize
Keizman, D. et al., “Metformin (met) use and outcome of sunitinib (Su) treatment (tx) in diabetic patients (pts) with metastatic renal cell carcinoma (mRCC);” (Israel)

Third Prize
Elsen, S. et al., “Evans blue as a diagnostic tool for non-muscle invasive bladder cancer.” (Belgium)